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Background
According to the scientific literature, proteasomes and
proteasomal genes which encode them may be important
in development of different chronic inflammatory diseases,
including asthma, through the activation of the NF-B
protein. We aimed to investigate expectancy of asthma in
subjects with different polymorphism of proteasomal
genes PSMA6 (rs1048990 and rs2277460), PSMC6
(rs2295827 and rs2295827) and PSMA3 (rs2348071) and
to analyze possible relation to gender, allergic status and
lung function.
Methods
296 individuals were involved in this study: 146 with mild
to moderate asthma (according to GINA) and 150
healthy subjects. Allergic status was evaluated using skin
prick test, blood eosinophil count and immunoglobulin E
(IgE) in serum. Lung function was measured by standard
spirometry. Alleles and genotypes of PSMA6 (rs1048990
and rs2277460), PSMC6 (rs2295827 and rs2295827) and
PSMA3 (rs2348071) were evaluated using allele specific
amplification and cleaved amplified polymorphic
sequence methods. DNA from peripheral blood was
extracted using Qiagen (Germany) DNA blood mini kit
(according to standardised protocol).
Results
Expectancy of asthma was similar in studied subjects
despite their proteasomal genes polymorphism: PSMA6
rs2277460 (CC) B=1.53, PSMA6 rs1048990 (CC) B=0.47,
PSMA6 rs1048990 (CG) B=0.52, PSMC6 rs2295826 (AA)
B=1.98, PSMC6 rs2295826 (AG) B=1.66, PSMC6
rs2295827 (CC) B=2.08, PSMC6 rs2295827 (CT) B=1.74,
PSMA3 rs2348071 (GG) B=1.20 and PSMA3 rs2348071
(GA) B=1.43. Asthma was diagnosed at the same fre-
quency in individuals having common genotype or at least
one rare genotype (rs1048990 GG, rs2295826 GG,
rs2295827 TT and rs2348071 AA) (50.4% vs. 41.7%). How-
ever, rs1048990 CG genotype was more common in males
with asthma than in healthy males (37.3% vs. 17.0%,
p<0.05). Analysis of blood eosinophil count showed signif-
icantly higher number of these cells in asthmatics with
common genotype than in asthmatics with rare genotype
(5.4% vs. 3.0%, p<0.05) and positive relation to this type of
proteasomal genes polymorphism (r=0.2, p<0.05). Positive
skin prick test, total IgE level and lung function results did
not differ significantly in these groups.
Conclusions
According to our study results, asthma is expected at the
same frequency in Lithuanian subjects despite their pro-
teasomal genes polymorphism type; however rs1048990
CG genotype is more prevalent in males with asthma.
Common genotype polymorphism is related to eosinophi-
lic asthma phenotype.
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